Early bird registration is open and closes May 2025. Register now

Days
Hrs
Mins

Latest Evidence on Methotrexate and JAK Inhibitors

Objectives:

This session will discuss the combination therapy of JAK inhibitors with MTX and JAK inhibitors monotherapy.

Agenda - Saturday 31 October
Chairperson: Dr Seong-Ho Kim, Republic of Korea
1730-1825
Latest Evidence on Methotrexate and JAK Inhibitors
Prof Yuko Kaneko, Japan

Share

Key dates

Registrations
Abstracts
Days
Hours
Minutes
Seconds
Until 11:59PM AEST Friday 24 April, 2026

The countdown is on

Have you submitted your abstract yet?
Don't miss your chance on being part of APLAR 2026 where live sessions feature the latest, best-in-class research and provide an opportunity to connect and stay apprised of the latest developments and innovations in the field.